Clinical Trial Update: An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of JNS001 in adults with Attention-Deficit Hyperactivity Disorder; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• JNS001

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Attention-Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-09-06